BBC Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD | US Stocks Today
Nov 10 at 4:00 PM ET (Korea 11/11 06:00)AI-drawn chart patterns are for reference only.
Full metrics table
| Category | US Equities - Industry Sector | Expense | 0.65% | Return% 1Y | 52.36% | Total Holdings | 130 | Perf Week | 4.84% | Volume | 54,143 |
| Asset Type | Equities (Stocks) | AUM | $32M | Return% 3Y | 36.17% | NAV | $45.10 | Perf Month | 4.23% | Avg Volume | 0.03M |
| ETF Type | US Equities | Dividend TTM | $0.66 (1.46%) | Return% 5Y | 0.2% | 52W High | -20.11% | Perf Quarter | -15.41% | Rel Volume | 1.79 |
| Active/Passive | Passive | Div Gr. 3/5Y | - | Return% 10Y | 9.83% | 52W Low | 47.29% | Perf Half Y | 0.76% | Prev Close | $44.99 |
| IPO | 2014/12/17 | Flows% 1M | -24.91% | Return% SI | 4.89% | RSI (14) | 54.47 | Perf YTD | 16.39% | Price | $44.88 |
| Beta | 0.94 | Flows% 3M | -24.91% | Flows% YTD | -15.61% | Flows% 1Y | 5.84% | Perf Year | 45.53% | Volatility(W/M) | 4.93% 3.71% |
| SMA20 | 6.06% | SMA50 | -1.35% | SMA200 | -1.76% | ATR | 1.7 | ||||
Virtus LifeSci Biotech Clinical Trials ETF seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
The top 10 make up 14% of the fund
Spread evenly across many holdings.
TRAX FIRST TRACKS BIOTHERAPEUTICS INC 1.67% 3 
MBX MBX BIOSCIENCES INC 1.24% 4 
ATAI ATAIBECKLEY INC 1.23% 5 
MNPR MONOPAR THERAPEUTICS INC 1.21% 6 
DFTX DEFINIUM THERAPEUTICS INC 1.18% 7 
XNCR XENCOR INC 1.10% 8 
QURE UNIQURE NV 1.06% 9 
ZBIO ZENAS BIOPHARMA INC 1.06% 10 
APGE APOGEE THERAPEUTICS INC 1.02% Largest sectors first.
Over the past 1 year, roughly in the middle
20% below its 1-year high.
Traded more than usual. That is 179% of its average volume.
Holding long would have lost money
Bought 5 years ago, your return today would be -1.0%. The S&P 500 did +62% over the same period.
Tap to view numbers
The price swings wildly
At its worst (February 2021) it fell 77% and has not fully recovered yet.
Tap to view numbers
The dividend is on the small side
Pays 1.46% annually in dividends.
Tap to view numbers
Money keeps flowing in
Over the past year, new money equal to 5.8% of assets came in.
Tap to view numbers
LABU Direxion Daily S&P Biotech Bull 3X ETF 617M 
MRNY YieldMax MRNA Option Income Strategy ETF 282M 
BIB ProShares Ultra Nasdaq Biotechnology 2X Shares 109M 
LABD-1× Direxion Daily S&P Biotech Bear 3X ETF 78M 
TBXU Direxion Daily Biotech Top 5 Bull 2X ETF 4M 
XLV State Street Health Care Select Sector SPDR ETF 0.08% 
VHT Vanguard Health Care ETF 0.09% 
XBI State Street SPDR S&P Biotech ETF 0.35% 
IYH iShares U.S. Healthcare ETF 0.37% 
IHI iShares U.S. Medical Devices ETF 0.37% 
SCHH Schwab U.S. REIT ETF 0.07% 
XLK State Street Technology Select Sector SPDR ETF 0.08% 
XLF State Street Financial Select Sector SPDR ETF 0.08% 
FAQ
How many holdings does BBC have?
BBC holds a total of 130 securities, with an AUM of approximately $32M.
Does BBC pay dividends (distributions)?
BBC's distribution yield is approximately 1.46%.
What is the 52-week high and low for BBC?
BBC has recorded a 52-week high of $56.18 and a low of $30.47.
